Overview

Liposomal Bupivacaine After Cesarean Delivery

Status:
Withdrawn

Trial end date:
2020-07-31

Target enrollment:

Participant gender:

Summary

The aim of this study is to determine if local wound infiltration with liposomal bupivacaine at the time of cesarean delivery can decrease opioid use and provide adequate post-operative pain control.

Phase:

Phase 4

Details

Lead Sponsor:

Wright State University

Treatments:

Bupivacaine